D Reintgen

601 total citations
24 papers, 485 citations indexed

About

D Reintgen is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, D Reintgen has authored 24 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Cancer Research. Recurrent topics in D Reintgen's work include Cutaneous Melanoma Detection and Management (14 papers), Melanoma and MAPK Pathways (3 papers) and Breast Cancer Treatment Studies (3 papers). D Reintgen is often cited by papers focused on Cutaneous Melanoma Detection and Management (14 papers), Melanoma and MAPK Pathways (3 papers) and Breast Cancer Treatment Studies (3 papers). D Reintgen collaborates with scholars based in United States. D Reintgen's co-authors include Seigler Hf, John T. Garbutt, William M. Thompson, Chris Puleo, Richard Heller, Ana M. Gamero, J Y Djeu, Rodolphe Perrot, Mark J. Jaroszeski and R. A. Gilbert and has published in prestigious journals such as Journal of Clinical Oncology, Melanoma Research and Archives of Otolaryngology - Head and Neck Surgery.

In The Last Decade

D Reintgen

24 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Reintgen United States 11 277 151 89 88 88 24 485
Josu Sola Spain 7 380 1.4× 259 1.7× 49 0.6× 140 1.6× 101 1.1× 12 705
Laura Vidal Spain 10 231 0.8× 79 0.5× 45 0.5× 135 1.5× 25 0.3× 23 465
R Nadeau United States 9 179 0.6× 271 1.8× 37 0.4× 122 1.4× 51 0.6× 13 491
Hong Pan China 12 198 0.7× 132 0.9× 26 0.3× 64 0.7× 20 0.2× 33 491
John Anderson United Kingdom 11 289 1.0× 58 0.4× 46 0.5× 261 3.0× 100 1.1× 18 611
Alison Humphreys United Kingdom 6 98 0.4× 76 0.5× 162 1.8× 66 0.8× 13 0.1× 16 311
Amy Sun United States 12 103 0.4× 162 1.1× 10 0.1× 115 1.3× 67 0.8× 22 441
Tyler O. Kirby United States 15 185 0.7× 52 0.3× 21 0.2× 173 2.0× 140 1.6× 27 608
D. C. Bodenham United Kingdom 8 420 1.5× 301 2.0× 20 0.2× 194 2.2× 129 1.5× 20 729
Zehra Kaymakcalan United States 8 53 0.2× 205 1.4× 19 0.2× 220 2.5× 59 0.7× 23 563

Countries citing papers authored by D Reintgen

Since Specialization
Citations

This map shows the geographic impact of D Reintgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Reintgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Reintgen more than expected).

Fields of papers citing papers by D Reintgen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Reintgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Reintgen. The network helps show where D Reintgen may publish in the future.

Co-authorship network of co-authors of D Reintgen

This figure shows the co-authorship network connecting the top 25 collaborators of D Reintgen. A scholar is included among the top collaborators of D Reintgen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Reintgen. D Reintgen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shivers, Steven C., et al.. (2001). Molecular analysis in evaluating the sentinel node in malignant melanoma.. PubMed. 8(9 Suppl). 29S–30S. 12 indexed citations
2.
Lengacher, Cecile A., et al.. (2001). The process of clinical trials: a model for successful clinical trial participation.. PubMed. 28(7). 1115–20. 18 indexed citations
3.
Reintgen, D, et al.. (2000). Metastatic melanoma to regional lymph nodes.. PubMed. 14(1). 213–20. 4 indexed citations
4.
Reintgen, D, et al.. (1998). The role of lymphoscintigraphy in lymphatic mapping for melanoma and breast cancer.. PubMed. 39(12). 22N, 25N, 32N, 36N–22N, 25N, 32N, 36N. 7 indexed citations
5.
Rapaport, David P., L. Frank Glass, C. Wayne Cruse, et al.. (1997). Comparison of techniques in locating sentinel nodes in patients with malignant melanoma. Melanoma Research. 7(Supplement 1). S105–S105. 1 indexed citations
6.
Glass, L. Frank, Ronald C. DeConti, C. Wayne Cruse, et al.. (1997). The results of complete lymph node dissections in 88 melanoma patients with positive sentinel nodes. Melanoma Research. 7(Supplement 1). S104–S104. 3 indexed citations
7.
Reintgen, D, John J. Albertini, David P. Rapaport, et al.. (1997). Investment in new technology research can save future health care dollars.. PubMed. 84(3). 175–81. 12 indexed citations
8.
Sharkey, Philip, Claudia G. Berman, & D Reintgen. (1997). Comparison of radiopharmaceuticals utilized in lymphoscintigraphy. Melanoma Research. 7(Supplement 1). S87–S87. 1 indexed citations
9.
Cantor, Alan, Frank Glass, Neil A. Fenske, et al.. (1997). Florida's undeclared epidemic: malignant melanoma.. PubMed. 84(3). 161–5. 3 indexed citations
10.
Rapaport, David P., Ronald C. DeConti, C. Wayne Cruse, et al.. (1997). Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of malignant melanoma.. PubMed. 84(3). 182–7. 10 indexed citations
11.
Brobeil, Andrea, et al.. (1997). The clinical relevance of sentinel lymph nodes identified with radiolymphoscintigraphy.. PubMed. 84(3). 157–60. 8 indexed citations
12.
Reintgen, D, et al.. (1997). The role of sentinel lymph node mapping for melanoma.. PubMed. 31. 79–103. 18 indexed citations
13.
Gershenwald, Jeffrey E., et al.. (1997). Nodal failure after lymphatic mapping (LM) and negative sentinel lymph node (SLN) biopsy in stage I or II melanoma patients. Melanoma Research. 7(Supplement 1). S29–S29. 2 indexed citations
14.
Gershenwald, Jeffrey E., et al.. (1997). Prognostic significance of the sentinel lymph node (SLN) in stage I or II melanoma patients. Melanoma Research. 7(Supplement 1). S105–S105. 5 indexed citations
15.
Albertini, John J., C Berman, Richard Heller, et al.. (1996). The tumor biology of melanoma nodal metastases.. PubMed. 62(1). 81–8. 45 indexed citations
16.
Gamero, Ana M., et al.. (1995). Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism.. PubMed. 55(21). 4988–94. 78 indexed citations
17.
Heller, Richard, et al.. (1995). Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy. Bioelectrochemistry and Bioenergetics. 36(1). 83–87. 90 indexed citations
18.
Reintgen, D, Courtney Cox, Harvey Greenberg, et al.. (1993). The medical legal implications of following mammographic breast masses.. PubMed. 59(2). 99–105. 12 indexed citations
19.
Reintgen, D, William M. Thompson, John T. Garbutt, & Seigler Hf. (1984). Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract.. PubMed. 95(6). 635–9. 108 indexed citations
20.
Gussack, Gerald S., et al.. (1983). Cutaneous Melanoma of the Head and Neck: A Review of 399 Cases. Archives of Otolaryngology - Head and Neck Surgery. 109(12). 803–808. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josu Sola Breakdown of academic impact, for papers by Laura Vidal Breakdown of academic impact, for papers by R Nadeau Breakdown of academic impact, for papers by Hong Pan Breakdown of academic impact, for papers by John Anderson Breakdown of academic impact, for papers by Alison Humphreys Breakdown of academic impact, for papers by Amy Sun Breakdown of academic impact, for papers by Tyler O. Kirby Breakdown of academic impact, for papers by D. C. Bodenham Breakdown of academic impact, for papers by Zehra Kaymakcalan
Rankless by CCL
2026